|
| U.S. Brand
Names |
|
| AK-Neo-Dex® Ophthalmic;
NeoDecadron® Ophthalmic; NeoDecadron® Topical;
Neo-Dexameth®
Ophthalmic |

|
|
| Generic
Available |
|
|
No |

|
|
| Synonyms |
|
|
Dexamethasone and Neomycin |

|
|
| Pharmacological Index |
|
|
Antibiotic/Corticosteroid, Ophthalmic; Antibiotic/Corticosteroid,
Topical |

|
|
| Use |
|
|
Treatment of steroid responsive inflammatory conditions of the palpebral and
bulbar conjunctiva, lid, cornea, and anterior segment of the
globe |

|
|
| Pregnancy Risk
Factor |
|
|
C |

|
|
| Adverse
Reactions |
|
|
<1%:
Ocular: Increased intraocular pressure, mydriasis, ptosis, epithelial
punctate keratitis, and possible corneal or scleral malacia can occur
|

|
|
| Stability |
|
|
Store in tight, light-resistant container |

|
|
| Usual Dosage |
|
|
Ophthalmic: Instill 1-2 drops in eye(s) every 3-4 hours
Topical: Apply thin coat 3-4 times/day until favorable response is observed,
then reduce dose to one application/day |

|
|
| Dental Health: Local
Anesthetic/Vasoconstrictor
Precautions |
|
|
No information available to require special precautions |

|
|
| Dental Health:
Effects on Dental Treatment |
|
|
No effects or complications reported |

|
|
| Patient
Information |
|
|
See individual agents. Pregnancy/breast-feeding precautions: Inform
prescriber if you are or intend to get pregnant. Consult prescriber if
breast-feeding. |

|
|
| Nursing
Implications |
|
|
May cause sensitivity to light, can minimize by wearing
sunglasses |

|
|
| Dosage Forms |
|
|
Cream: Neomycin sulfate 0.5% [5 mg/g] and dexamethasone 0.1% [1 mg/g] (15 g,
30 g)
Ointment, ophthalmic: Neomycin sulfate 0.35% [3.5 mg/g] and dexamethasone
0.05% [0.5 mg/g] (3.5 g)
Solution, ophthalmic: Neomycin sulfate 0.35% [3.5 mg/mL] and dexamethasone
0.1% [1 mg/mL] (5 mL) |

|
|
Copyright © 2007 Drugs Area
|